Implantation of Wireless Pacemaker Carried Out at Seesener Klinik
## Asklepios Clinic Schildautal Pioneers Minimally Invasive Wireless Pacemaker Treatment
The Asklepios Clinic Schildautal in Lower Saxony, Germany, has made a significant stride in the field of cardiology with the successful implementation of a minimally invasive wireless pacemaker treatment for heart rhythm disorders. This groundbreaking procedure, performed by Prof. Dr. Hendrik Bonnemeier and his team, marks the first of its kind at the clinic.
The innovative treatment involves the insertion of a wireless pacemaker, manufactured by Abbott, into the heart via a catheter from the groin. The device, which is 3.8 centimeters in size and comes without electrodes, is particularly beneficial for certain patient groups, including the elderly and those with pre-existing conditions.
The wireless pacemaker treatment offers several advantages over traditional pacemaker methods. It reduces complications associated with lead use, such as infections and heart tissue damage. The implantation process is less invasive, resulting in quicker recovery times and fewer procedural risks. Moreover, these modern pacemakers are MRI-safe and often feature wireless connectivity, enhancing patient safety and facilitating remote monitoring and adjustments.
The cost-effectiveness of the wireless pacemaker treatment is another significant advantage. Although the initial costs may be higher, these devices can offer long-term cost savings by reducing the need for follow-up surgeries and minimizing hospital stays.
The adoption and growth of minimally invasive wireless pacemaker treatments are on the rise globally, and Germany is no exception. The European market, including Germany, is experiencing growth in the adoption of leadless pacemakers due to their technological advancements and patient safety benefits. Germany's regulatory environment supports innovative medical technologies, including advanced pacemakers, ensuring the country remains at the forefront of these advancements.
Prof. Bonnemeier, the new chief physician of the Clinic for Internal Medicine and Cardiology at the Schildautal Clinic, is one of the pioneers of this innovative treatment method. With extensive experience in the implantation of wireless heart implants, he and his team are well-equipped to lead the way in this exciting new development in cardiology.
The Asklepios Harzkliniken were one of the few clinics in Lower Saxony to apply the wireless pacemaker treatment procedure. With this latest development, the Schildautal Clinic is now one of the clinics in Lower Saxony to perform the wireless pacemaker treatment procedure, further cementing its reputation as a centre of excellence in cardiology.
[1] European Heart Journal. (2021). Leadless pacemakers: a systematic review and meta-analysis of clinical outcomes. [2] European Society of Cardiology. (2021). Leadless pacemakers: current status and future perspectives. [3] European Commission. (2020). Medical devices regulation: a new regulatory framework. [4] Abbott. (2021). Abbott's next-generation wireless pacemaker receives CE mark in Europe. [5] Abbott. (2021). Abbott's next-generation wireless pacemaker approved in the U.S.
Science has played a significant role in the improvement of medical-conditions, as demonstrated by the innovative minimally invasive wireless pacemaker treatment that enhances health-and-wellness, particularly cardiovascular-health, through reduced complications and quicker recovery times. The adoption and advancement of this technology, such as the one used at the Asklepios Clinic Schildautal, is globally on the rise, with Germany being a key player due to its supportive regulatory environment.
